Aileron Therapeutics Inc ALRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
3.82quote price arrow down-0.34 (-8.17%)
Volume
148,272
52 week range
1.01 - 7.42
Loading...
  • Open4.29
  • Day High4.30
  • Day Low3.76
  • Prev Close4.16
  • 52 Week High7.42
  • 52 Week High Date04/18/24
  • 52 Week Low1.01
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap64.835M
  • Shares Out16.97M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.19
  • YTD % Change25.3

KEY STATS

  • Open4.29
  • Day High4.30
  • Day Low3.76
  • Prev Close4.16
  • 52 Week High7.42
  • 52 Week High Date04/18/24
  • 52 Week Low1.01
  • 52 Week Low Date10/31/23
  • Market Cap64.835M
  • Shares Out16.97M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta2.19
  • YTD % Change25.3

RATIOS/PROFITABILITY

  • EPS (TTM)-3.39
  • P/E (TTM)-1.13
  • Fwd P/E (NTM)-6.14
  • EBITDA (TTM)-15.229M
  • ROE (TTM)-123.34%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aileron Therapeutics Inc

 

Profile

MORE
Aileron Therapeutics, Inc. is a biopharmaceutical company. The Company is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its...
Josef von Rickenbach
Independent Chairman of the Board
Brian Windsor Ph.D.
President, Chief Executive Officer, Director
Charles Garner
Principal Financial Officer
Address
12407 N. Mopac Expy., Suite 250 #390
Austin, TX
78758
United States

Top Peers

SYMBOLLASTCHG%CHG
RVPH
Reviva Pharmaceuticals Holdings, Inc.
3.18-0.08-2.45%
JSPR
Jasper Therapeutics Inc
23.98-0.01-0.04%
SLS
Sellas Life Sciences Group Inc
1.35+0.07+5.47%
PASG
Passage Bio Inc
1.34-0.01-0.74%
CMRX
Chimerix Inc
0.9502+0.0002+0.0211%